Concepedia

Marco Frigeni

MF

13

Publications

805

Citations

11

H-Index

2016

Active since

Affiliations

Istituti di Ricovero e Cura a Carattere Scientifico(Current)

University of Pavia

Policlinico San Matteo Fondazione

Ospedale Papa Giovanni XXIII

Azienda Ospedaliera Universitaria Senese

Marco Frigeni is an author at Istituti di Ricovero e Cura a Carattere Scientifico specializing in medicine, immunology, and pathology.

ORCID

Top concepts

Publications per year

2016–2024

13

Publications

13

Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection

Luca Arcaini, Caroline Besson, Marco Frigeni et al. · Blood · 2016 · 171 citations · Full text

IL-6 signalling pathway inactivation with siltuximab in patients with COVID-19 respiratory failure: an observational cohort study

Giuseppe Gritti, Federico Raimondi, Diego Ripamonti et al. · 2020 · 170 citations · Full text

, , +26

Endothelial injury and thrombotic microangiopathy in COVID-19: Treatment with the lectin-pathway inhibitor narsoplimab

Alessandro Rambaldi, Giuseppe Gritti, Maria Caterina Micò et al. · Immunobiology · 2020 · 148 citations · Full text

, , +10

Early progression as a predictor of survival in marginal zone lymphomas: an analysis from the FIL-NF10 study

Stefano Luminari, Michele Merli, Sara Rattotti et al. · Blood · 2019 · 79 citations · Full text

Direct-Acting Antivirals in Hepatitis C Virus-Associated Diffuse Large B-cell Lymphomas

Michele Merli, Marco Frigeni, Laurent Alric et al. · The Oncologist · 2018 · 65 citations · Full text

Rows per page

1–5 of 13